Publications by authors named "Florent Courrech"
Article Synopsis
- The study investigated factors affecting local control and progression-free survival (PFS) in cervical cancer patients treated with utero-vaginal brachytherapy after chemoradiotherapy from 2005 to 2015.
- Among 218 patients, local control rates were high, with 87.8% at 2 years and 87.2% at 5 years, and PFS rates were 67.6% at 2 years and 57.4% at 5 years, while various factors were found to influence these outcomes.
- Key findings included the significance of T stage, para-aortic nodal disease, and pathological complete response, suggesting that lower brachytherapy doses may be effective for earlier-stage
Stereotactic radiotherapy (SRT) is recommended for treatment of brain oligometastasis (BoM) in patients with controlled primary disease. Where contrast enhancement enlargement occurs during follow-up, distinguishing between radionecrosis and progression presents a critical challenge. Without pathological confirmation, decision-making may be inappropriate and delayed.
View Article and Find Full Text PDFPurpose: To evaluate the impact of bladder distension on doses to organs at risk in patients treated with 3D image-guided adaptive pulsed-dose-rate (PDR) brachytherapy (BT) for locally advanced cervical cancer.
Methods And Materials: Twenty-two patients who had previously been treated by external beam radiation therapy (EBRT), underwent BT treatment planning to a pelvic MRI (or a CT scan in case of contraindication) after their bladder was filled with 100 cc of physiological saline (full bladder). This was immediately followed by a CT scan after emptying of the bladder.